14th Asia-Pacific Breast Cancer Summit 2026 shared a post on LinkedIn:
” ‘We were privileged to have world-class speakers share practice-changing insights.’ – Dr. Wong Nan Soon, Mount Elizabeth Hospitals, Singapore
At APBCS2025, we reflected on highlights from the San Antonio Breast Cancer Symposium (SABCS), including the EMBER-3 abstract, which stood out for its potential to advance care for patients previously treated with CDK4/6 inhibitors and chemotherapy.
Thank you, Dr. Wong, for spotlighting how abstracts can shape the future of breast cancer oncology.
If you are working on original research, case studies, or clinical trials, APBCS 2026 in Malaysia is your platform to share and inspire change.
See you at the 14th Asia Pacific Breast Cancer Summit in Malaysia, 2026.
To submit your abstracts, visit here.”
Proceed to the video attached to the post.
More posts featuring APBCS2025 on OncoDaily.